title: Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese.
abstract: We analyzed the serum concentrations of lipids and lipoproteins and the prevalence of other risk factors in a case-control study of 304 consecutive Chinese patients with acute stroke (classified as cerebral infarction, lacunar infarction, or intracerebral hemorrhage) and 304 age- and sex-matched controls. For all strokes we identified the following risk factors: a history of ischemic heart disease, diabetes mellitus, or hypertension; the presence of atrial fibrillation or left ventricular hypertrophy; a glycosylated hemoglobin A1 concentration of greater than 9.1%; a fasting plasma glucose concentration 3 months after stroke of greater than 6.0 mmol/l; a serum triglyceride concentration 3 months after stroke of greater than 2.1 mmol/l; and a serum lipoprotein(a) concentration of greater than 29.2 mg/dl. We found the following protective factors: a serum high density lipoprotein-cholesterol concentration of greater than 1.59 mmol/l and a serum apolipoprotein A-I concentration of greater than or equal to 106 mg/dl. The patterns of risk factors differed among the three stroke subtypes. When significant risk factors were entered into a multiple logistic regression model, we found a history of hypertension, a high serum lipoprotein(a) concentration, and a low apolipoprotein A-I concentration to be independent risk factors for all strokes. The attributable risk for hypertension was estimated to be 24% in patients aged greater than or equal to 60 years. In this population, in which cerebrovascular diseases are the third commonest cause of mortality, identification of risk factors will allow further studies in risk factor modification for the prevention of stroke.
authors.affiliation: Department of Medicine, Chinese University of Hong Kong.
authors.forename: J
authors.initials: J
authors.lastname: Woo
authors.forename: E
authors.initials: E
authors.lastname: Lau
authors.forename: C W
authors.initials: CW
authors.lastname: Lam
authors.forename: R
authors.initials: R
authors.lastname: Kay
authors.forename: R
authors.initials: R
authors.lastname: Teoh
authors.forename: H Y
authors.initials: HY
authors.lastname: Wong
authors.forename: W Y
authors.initials: WY
authors.lastname: Prall
authors.forename: L
authors.initials: L
authors.lastname: Kreel
authors.forename: M G
authors.initials: MG
authors.lastname: Nicholls
mesh_terms: D016632:Apolipoprotein A-I; D001054:Apolipoproteins A / Q000097:blood*; D016022:Case-Control Studies; D002561:Cerebrovascular Disorders / Q000208:ethnology / Q000209:etiology*; D002681:China / Q000208:ethnology; D006723:Hong Kong; D006801:Humans; D006973:Hypertension / Q000150:complications*; D017270:Lipoprotein(a); D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008875:Middle Aged; D009994:Osmolar Concentration; D012307:Risk Factors
chemical_list: D016632:Apolipoprotein A-I; D001054:Apolipoproteins A; D017270:Lipoprotein(a); D008074:Lipoproteins; D008075:Lipoproteins, HDL